JP2025512957A5 - - Google Patents
Info
- Publication number
- JP2025512957A5 JP2025512957A5 JP2024559157A JP2024559157A JP2025512957A5 JP 2025512957 A5 JP2025512957 A5 JP 2025512957A5 JP 2024559157 A JP2024559157 A JP 2024559157A JP 2024559157 A JP2024559157 A JP 2024559157A JP 2025512957 A5 JP2025512957 A5 JP 2025512957A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- independently selected
- appropriately substituted
- membered
- halo
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263327631P | 2022-04-05 | 2022-04-05 | |
| US63/327,631 | 2022-04-05 | ||
| PCT/US2023/017384 WO2023196283A1 (en) | 2022-04-05 | 2023-04-04 | Egfr inhibitors |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025512957A JP2025512957A (ja) | 2025-04-22 |
| JP2025512957A5 true JP2025512957A5 (enExample) | 2026-04-13 |
Family
ID=86286433
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024559157A Pending JP2025512957A (ja) | 2022-04-05 | 2023-04-04 | Ｅｇｆｒ阻害剤 |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20250236608A1 (enExample) |
| EP (1) | EP4504719A1 (enExample) |
| JP (1) | JP2025512957A (enExample) |
| KR (1) | KR20250012554A (enExample) |
| CN (1) | CN119325471A (enExample) |
| AR (1) | AR129002A1 (enExample) |
| AU (1) | AU2023250382A1 (enExample) |
| CA (1) | CA3247645A1 (enExample) |
| IL (1) | IL315980A (enExample) |
| MX (1) | MX2024012267A (enExample) |
| PY (1) | PY2325218A (enExample) |
| TW (1) | TW202404590A (enExample) |
| UY (1) | UY40220A (enExample) |
| WO (1) | WO2023196283A1 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025080786A1 (en) * | 2023-10-11 | 2025-04-17 | Blueprint Medicines Corporation | Salt and solid forms of an egfr inhibitor |
| WO2025080784A1 (en) * | 2023-10-11 | 2025-04-17 | Blueprint Medicines Corporation | Egfr inhibitors |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2012066122A1 (en) * | 2010-11-18 | 2012-05-24 | Syngenta Participations Ag | 2 - (pyridin- 2 -yl) -quinazoline derivatives and their use as microbicides |
| CN110498804A (zh) * | 2018-05-18 | 2019-11-26 | 山东轩竹医药科技有限公司 | 喹唑啉衍生物类酪氨酸激酶抑制剂的新用途 |
| TW202012391A (zh) * | 2018-07-04 | 2020-04-01 | 日商第一三共股份有限公司 | 二芳基醚型喹唑啉衍生物 |
| JP7752617B2 (ja) | 2019-12-23 | 2025-10-10 | ブループリント メディシンズ コーポレイション | Ｅｇｆｒの変異型の阻害剤 |
-
2023
- 2023-03-31 TW TW112112529A patent/TW202404590A/zh unknown
- 2023-04-04 WO PCT/US2023/017384 patent/WO2023196283A1/en not_active Ceased
- 2023-04-04 EP EP23721090.1A patent/EP4504719A1/en active Pending
- 2023-04-04 KR KR1020247036844A patent/KR20250012554A/ko active Pending
- 2023-04-04 JP JP2024559157A patent/JP2025512957A/ja active Pending
- 2023-04-04 CA CA3247645A patent/CA3247645A1/en active Pending
- 2023-04-04 PY PY202302325218A patent/PY2325218A/es unknown
- 2023-04-04 IL IL315980A patent/IL315980A/en unknown
- 2023-04-04 US US18/853,933 patent/US20250236608A1/en active Pending
- 2023-04-04 CN CN202380044824.6A patent/CN119325471A/zh active Pending
- 2023-04-04 AU AU2023250382A patent/AU2023250382A1/en active Pending
- 2023-04-05 AR ARP230100850A patent/AR129002A1/es unknown
- 2023-04-10 UY UY0001040220A patent/UY40220A/es unknown
-
2024
- 2024-10-03 MX MX2024012267A patent/MX2024012267A/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN117327102B (zh) | Kras抑制剂、其制备方法及应用 | |
| TW391960B (en) | Pharmaceutical composition containing tachykinin antagonistic piperazine derivatives | |
| EP4380561A1 (en) | Conjugates comprising covalent binders for targeting intracellular kras g12c proteins | |
| CN110156770B (zh) | 作为tam族激酶抑制剂的氨基吡啶衍生物 | |
| ES2701069T3 (es) | Inhibidores de PRMT5 y sus usos | |
| ES2817902T3 (es) | N-acil-N'-(piridin-2-il) ureas y análogos que presentan actividades anticancerosas y antiproliferativas | |
| US11084784B2 (en) | ROR-gamma modulators and uses thereof | |
| US6887874B2 (en) | Cinnoline compounds | |
| JP2020529987A5 (enExample) | ||
| JP2025540958A (ja) | 蕁麻疹の治療のための野生型ｃ－ｋｉｔキナーゼ阻害剤としてのＮ－フェニル－ピラゾロ［１，５－Ａ］ピリジン－３－カルボキサミド誘導体 | |
| AU2018321567A1 (en) | Ether compounds and uses thereof | |
| JP2018531982A5 (enExample) | ||
| CA3161892A1 (en) | Combinations of estrogen receptor degraders and cyclin-dependent kinase inhibitors for treating cancer | |
| JP2004505964A (ja) | Ｖｅｇｆ阻害活性を有するキノリン誘導体 | |
| JP2004505965A (ja) | 化合物 | |
| US11008318B2 (en) | 2-phenylimidazo[4,5-b]pyridin-7-amine derivates useful as inhibitors of mammalian tyrosine kinase ROR1 activity | |
| JP2023535279A (ja) | ４級インダゾールグルココルチコイド受容体アンタゴニスト | |
| CA2773590C (en) | 8-oxodihydropurine derivative | |
| KR20240125035A (ko) | 이환 인다졸 글루코코르티코이드 수용체 길항제 | |
| JP7168245B2 (ja) | 三環式化合物 | |
| JP2012031152A (ja) | 新規２環性複素環化合物からなる医薬 | |
| JP2025512957A (ja) | Ｅｇｆｒ阻害剤 | |
| JP2025500318A (ja) | ピペラジンインダゾールグルココルチコイド受容体拮抗薬 | |
| AU2022406595B2 (en) | Anti-apoptotic protein bcl-2 inhibitor, pharmaceutical composition and uses thereof | |
| TWI847445B (zh) | 一種噠嗪類化合物、其藥物組合物及應用 |